Davies Sally S - OmicsDI

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Characterising meaningful patient and public involvement in the pharmaceutical industry research setting: a retrospective quality assessment.

Not available

S-EPMC10450071 | biostudies-literature

Gene expression changes in embryonic stem cells in response to Tcf15-E47

We set out to identify genes that respond rapidly to overexpression of a Tcf15-E47 heterodimeric transcription factor in mouse embryonic stem cells. Dox inducible Tcf15-E47 mouse embryonic stem cells were exposed to dox for 0, 8, 12, 24h and samples collected in duplicate. Control parental cells we...

ORGANISM(S): Mus musculus

2013-02-08 | E-GEOD-42539 | biostudies-arrayexpress

Functional and genetic heterogeneity of distinctive leukaemic stem cell populations in CD34- human Acute Myeloid Leukaemia

We performed RNA-sequencing of normal haematopoietic stem cells and progenitor populations and of Leukemic Stem Cells in CD34- Acute Myeloid Leukaemia.

ORGANISM(S): Homo sapiens

2016-06-22 | E-MTAB-2672 | biostudies-arrayexpress

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.

Not available

S-EPMC5838871 | biostudies-literature

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.

Not available

S-EPMC6617509 | biostudies-literature

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.

Not available

S-EPMC8757570 | biostudies-literature

Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.